» Articles » PMID: 35041692

Quality of Life of Patients with Rheumatic Diseases During the COVID-19 Pandemic: The Biopsychosocial Path

Abstract

Background: Previous models that assess quality-of-Life (QoL) in patients with rheumatic diseases have a strong biomedical focus. We evaluated the impact of COVID-19 related-health care interruption (HCI) on the physical, psychological, social relationships and environment QoL-dimensions, and explored factors associated with QoL when patients were reincorporated to the outpatient clinic, and after six-month follow-up.

Patients And Methods: Study phase-1 consisted of a COVID-19 survey administered from June 24th-October 31st 2020, to outpatients with rheumatic diseases who had face-to-face consultation at outpatient clinic reopening. Study phase-2 consisted of 3 consecutive assessments of patient´s QoL (WHOQOL-BREF), disease activity/severity (RAPID-3), and psychological comorbidity/trauma (DASS-21 and IES-R) to patients from phase-1 randomly selected. Sociodemographic, disease and treatment-related information, and comorbidities were obtained. Multiple linear regression analysis identified factors associated with the score assigned to each WHOQOL-BREF dimension.

Results: Patients included (670 for phase-1 and 276 for phase-2), had primarily SLE and RA (44.2% and 34.1%, respectively), and all the dimensions of their WHOQOL-BREF were affected. There were 145 patients (52.5%) who referred HCI, and they had significantly lower dimensions scores (but the environment dimension score). Psycho-emotional factors (primarily feeling confused, depression and anxiety), sociodemographic factors (age, COVID-19 negative economic impact, years of scholarship, HCI and having a job), and biomedical factors (RAPID-3 score and corticosteroid use) were associated with baseline QoL dimensions scores. Psycho-emotional factors showed the strongest magnitude on dimensions scores. Most consistent predictor of six-month follow-up QoL dimensions scores was each corresponding baseline dimension score, while social determinants (years of scholarship and having a job), emotional factors (feeling bored), and biomedical aspects (RAPID 3) had an additional impact.

Conclusions: HCI impacted the majority of patient´s QoL dimensions. Psycho-emotional, sociodemographic and biomedical factors were consistently associated with QoL dimensions scores, and these consistently predicted the QoL trajectory.

Citing Articles

Sexual and reproductive health while living with rheumatoid arthritis: The impact of the disease stage on patient perspectives.

Ledon-Llanes L, Contreras-Yanez I, Guaracha-Basanez G, Valverde-Hernandez S, Cuevas-Montoya M, Ortiz-Haro A PLoS One. 2024; 19(4):e0302284.

PMID: 38669255 PMC: 11051615. DOI: 10.1371/journal.pone.0302284.


A Single-Session Process-Based Cognitive-Behavioral Intervention Combined with Multimodal Rehabilitation Treatment for Chronic Pain Associated with Emotional Disorders.

Cojocaru C, Popa C, Schenk A, Jakab Z, Suciu B, Olah P Behav Sci (Basel). 2024; 14(4).

PMID: 38667123 PMC: 11047417. DOI: 10.3390/bs14040327.


Adequacy of the WHOQoL-BREF to Assess the Quality of Life of Victims of Armed Conflicts.

Morales-Valiente C, Mok L, Wong A, Manzanero A, Guarch-Rubio M, Simancas M Assessment. 2023; 31(5):1135-1147.

PMID: 37902160 PMC: 11134973. DOI: 10.1177/10731911231201145.


Surviving COVID-19: Biopsychosocial Impacts, Death Anxiety, and Coping Strategies.

Muazzam A, Naseem F, Shakil M, Visvizi A, Klemens J Vaccines (Basel). 2023; 11(3).

PMID: 36992289 PMC: 10057707. DOI: 10.3390/vaccines11030705.


The impact of the COVID-19 pandemic and stringent social distancing measures on health-related quality of life and COVID-19 infection rates in patients with rheumatic disease: a longitudinal analysis through the pandemic.

Cox N, Raizada S, Barkham N, Venkatachalam S, Sheeran T, Adizie T Rheumatol Adv Pract. 2023; 7(1):rkad009.

PMID: 36751643 PMC: 9897299. DOI: 10.1093/rap/rkad009.


References
1.
Kivits J, Erpelding M, Guillemin F . Social determinants of health-related quality of life. Rev Epidemiol Sante Publique. 2013; 61 Suppl 3:S189-94. DOI: 10.1016/j.respe.2013.06.001. View

2.
Verbrugge L, Juarez L . Profile of arthritis disability: II. Arthritis Rheum. 2006; 55(1):102-13. DOI: 10.1002/art.21694. View

3.
de Mol M, Visser S, Aerts J, Lodder P, de Vries J, Den Oudsten B . Satisfactory results of a psychometric analysis and calculation of minimal clinically important differences of the World Health Organization quality of life-BREF questionnaire in an observational cohort study with lung cancer and mesothelioma.... BMC Cancer. 2018; 18(1):1173. PMC: 6260568. DOI: 10.1186/s12885-018-4793-8. View

4.
Russell A, Gulliver W, Irvine E, Albani S, Dutz J . Quality of life in patients with immune-mediated inflammatory diseases. J Rheumatol Suppl. 2011; 88:7-19. DOI: 10.3899/jrheum.110899. View

5.
Antony A, Connelly K, De Silva T, Eades L, Tillett W, Ayoub S . Perspectives of Patients With Rheumatic Diseases in the Early Phase of COVID-19. Arthritis Care Res (Hoboken). 2020; 72(9):1189-1195. PMC: 7300883. DOI: 10.1002/acr.24347. View